Metagenomi Therapeutics MGX
NASDAQ MGX
$1.09 -0.01 (-1.36%)
As of: Oct 2, 2026 · 9:42 AM EDT

Metagenomi Therapeutics (MGX) Depreciation & Amortization (CF) (2023 - 2026)

Updated

Metagenomi Therapeutics (MGX) recorded Depreciation & Amortization (CF) of $1.27 million in Q2 2026, down 5.2% from $1.34 million a year earlier and down 0.8% from the prior quarter.

Analysis

Metagenomi Therapeutics (MGX) Depreciation & Amortization (CF) (2023 - 2026) Analysis & Trends

On a TTM basis, Metagenomi Therapeutics' Depreciation & Amortization (CF) came in at $5.16 million as of Jun 30, 2026, down 6.4% year-over-year; for FY2025, it was $5.32 million, down 1.7% from FY2024.

  • Across earlier years, Depreciation & Amortization (CF) came in at $5.41 million in FY2024 (+28.5%) and $4.21 million in FY2023.
  • The Q2 2026 figure is the lowest quarterly Depreciation & Amortization (CF) since Q4 2023.
  • On a year-over-year basis, Depreciation & Amortization (CF) has declined for four consecutive quarters, with growth averaging 2.9% over the last eight quarters.
  • Peak year-over-year performance for Depreciation & Amortization (CF) in the last five years was growth of 51.4% in Q1 2024, against a decline of 11.0% in Q4 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $1.28 million (Q1 2026), $1.3 million (Q4 2025) and $1.32 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Metagenomi Therapeutics 40.04 Mn 40.04 Mn - 1.27 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.27 Mn
Mar 31, 2026 1.28 Mn
Dec 31, 2025 1.30 Mn
Sep 30, 2025 1.32 Mn
Jun 30, 2025 1.34 Mn
Mar 31, 2025 1.36 Mn
Dec 31, 2024 1.46 Mn
Sep 30, 2024 1.36 Mn
Jun 30, 2024 1.31 Mn
Mar 31, 2024 1.27 Mn
Dec 31, 2023 1.20 Mn
Sep 30, 2023 1.15 Mn
Jun 30, 2023 1.01 Mn
Mar 31, 2023 841,000.00
API Access

Metagenomi Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=MGX&period=max&api_key=YOUR_API_KEY